MANDILLO, SILVIA
 Distribuzione geografica
Continente #
AS - Asia 2.971
NA - Nord America 1.662
EU - Europa 837
SA - Sud America 528
AF - Africa 54
OC - Oceania 8
Totale 6.060
Nazione #
US - Stati Uniti d'America 1.558
SG - Singapore 1.183
CN - Cina 674
BR - Brasile 439
HK - Hong Kong 386
IT - Italia 311
VN - Vietnam 290
FR - Francia 180
KR - Corea 147
DE - Germania 72
JP - Giappone 67
IN - India 62
GB - Regno Unito 50
NL - Olanda 47
BD - Bangladesh 45
CA - Canada 37
AR - Argentina 35
MX - Messico 35
FI - Finlandia 34
ID - Indonesia 26
AT - Austria 23
ES - Italia 18
EC - Ecuador 17
IL - Israele 17
RU - Federazione Russa 14
TR - Turchia 14
ZA - Sudafrica 14
PK - Pakistan 11
CH - Svizzera 9
CO - Colombia 9
JM - Giamaica 9
LT - Lituania 9
PL - Polonia 9
SE - Svezia 9
IQ - Iraq 8
KE - Kenya 8
MA - Marocco 8
PY - Paraguay 8
AL - Albania 7
AU - Australia 7
CL - Cile 7
EG - Egitto 7
CR - Costa Rica 6
EE - Estonia 6
IE - Irlanda 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
JO - Giordania 5
VE - Venezuela 5
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
PT - Portogallo 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UA - Ucraina 4
DO - Repubblica Dominicana 3
HR - Croazia 3
MY - Malesia 3
RO - Romania 3
SV - El Salvador 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
SA - Arabia Saudita 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
BF - Burkina Faso 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GM - Gambi 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
LB - Libano 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RS - Serbia 1
RW - Ruanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 6.060
Città #
Singapore 732
Hong Kong 385
Santa Clara 349
Hefei 250
San Jose 218
Rome 150
Ashburn 148
Beijing 148
Seoul 144
Lauterbourg 133
Ho Chi Minh City 106
Dallas 100
Los Angeles 86
Hanoi 75
Tokyo 47
New York 40
São Paulo 35
Frankfurt am Main 31
Orem 25
Milan 24
Buffalo 19
Naples 19
Avellino 18
Da Nang 17
Chennai 16
Turku 15
Nuremberg 14
Minamishinagawa 13
Vienna 13
Helsinki 12
Montreal 12
Munich 12
Curitiba 11
Rio de Janeiro 11
Bengaluru 10
Brooklyn 10
Dublin 10
Haiphong 10
London 10
Atlanta 9
Chicago 9
Houston 9
Mexico City 9
Ankara 8
Brasília 8
Quito 8
Amsterdam 7
Belo Horizonte 7
Dhaka 7
Fortaleza 7
Hangzhou 7
Lahore 7
Lappeenranta 7
Nairobi 7
Poplar 7
Shanghai 7
Stockholm 7
Warsaw 7
Guarulhos 6
Guayaquil 6
Jakarta 6
Johannesburg 6
Kingston 6
Manchester 6
Phoenix 6
Salvador 6
Sydney 6
Tashkent 6
Toronto 6
Zurich 6
Betim 5
Campinas 5
Caxias do Sul 5
Council Bluffs 5
Denver 5
Elk Grove Village 5
Guangzhou 5
Ha Long 5
Hải Dương 5
Mumbai 5
Paris 5
Piracicaba 5
Querétaro 5
Rae Parish 5
Ribeirão Preto 5
San Francisco 5
Shenzhen 5
Thái Bình 5
Tirana 5
Acalanes Ridge 4
Asunción 4
Baghdad 4
Birmingham 4
Boardman 4
Cairo 4
Changsha 4
City of London 4
Columbia 4
Durban 4
Haarlem 4
Totale 3.833
Nome #
Novel DVC interlinking home cage monitoring system facilitates social behavioural testing in mice 155
PCTO per insegnanti e studenti della scuola secondaria superiore: STEM4H (StemCells for human health) 145
Inhalation of nanoplastics in the mouse model: tissue biodistribution and effects on the olfactory system 136
Brain and behavioural anomalies caused by Tbx1 haploinsufficiency are corrected by vitamin B12 122
Inhalation of nanoplastics in the mouse model: Tissue bio-distribution and effects on the olfactory system 119
Muscle‐specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1 105
A large scale hearing loss screen reveals an extensive unexplored genetic landscape for auditory dysfunction 102
Identification of genetic elements in metabolism by high-throughput mouse phenotyping 92
BEHAVIOURAL ABNORMALITIES IN DMSXL MICE, A MODEL OF MYOTONIC DYSTROPHY TYPE 1 87
Muscle-specific gene editing improves molecular and phenotypic defects in a mouse model of Myotonic Dystrophy type 1 84
Nucleus accumbens dopamine receptors in the consolidation of spatial memory 81
Y-Maze: SOP and Analysis 79
Inhalation of nanoplastics in the mouse model: tissue bio-distribution and effects on the olfactory system 78
Inducible CRISPR/Cas9 strategy mediates efficient gene editing of trinucleotide repeat expansion in DMPK locus 76
A systematic review of the development and application of home cage monitoring in laboratory mice and rats 75
Co-expression of prepulse inhibition and schizophrenia genes in the mouse and human brain 73
Study of pathogenetic mechanisms and development of new therapeutic strategies for Myotonic Dystrophy type 1 72
Home cage monitoring uncovers sleep-related phenotypes in mouse models of ALS and DM1 71
Application of CRISPR/Cas9 strategy for gene therapy of Myotonic Dystrophy type 1 69
CXCR2 increases in ALS cortical neurons and its inhibition prevents motor neurons degeneration in vitro and improves neuromuscular function in SOD1G93A mice 69
Sleep-related phenotypes are non-invasively uncovered using home cage monitoring in mouse models of ALS and DM1 68
GENE EDITING IN MYOTONIC DYSTROPHY TYPE 1: ASSESSMENT OF EFFICIENCY, SAFETY AND THERAPEUTIC EFFECT OF CTG-REPEAT DELETION IN A MOUSE MODEL OF DISEASE 66
Gene Therapy Strategies For Myotonic Dystrophy Type 1 65
Differences in visual information processing style between Idiopathic Generalized Epilepsy with and without photosensitivity 64
Più libri, più liberi», Fiera del Libro di Roma 2024. Sfoglia un libro, accendi il cervello! 64
Software Development-MouseWatch: a program for recording mouse behaviour 61
Behavioural alterations in mice lacking the Parkinson's disease associated GPR37 receptor 60
D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice. 59
Behavioral characterization of EUMODIC mutant lines 57
Wheel Running Adversely Affects Disease Onset and Neuromuscular Interplay in Amyotrophic Lateral Sclerosis Slow Progression Mouse Model 56
The Parkinson's disease associated GPR37 receptor interacts with DAT to modulate dopamine uptake and behavioural responses to dopaminergic drugs 55
Setting-up a multimodal and integrated sensory platform to analyze the impact of two mouse models (C57BL6/N; CD-1) in aging research 54
Assessing olfactory and taste functions in mouse behavioral phenotyping 53
CNR-EBRI-EMBL-ICGEB Monterotondo Workshop 2010 Presentations 52
Role of hippocampus on amphetamine induced conditioned locomotor response 51
GPR37/PAEL-R knock-out mice show abnormalities in nigro-striatal dopaminergic function. 51
Altered behavioral responses to psychostimulants in mice lacking GPR37/Pael receptor are linked to its interaction with the dopamine transporter 51
Response, use and habituation to a mouse house in C57BL/6J and BALB/c mice 51
Excessive rest time during active phase is reliably detected in a mouse model of myotonic dystrophy type 1 using home cage monitoring 51
European comprehensive first-line phenotyping protocol for mice: results from a primary screen to evaluate behaviour and cognition 50
Home cage detection of sleep disturbances in a mouse model of ALS 49
GENE EDITING IN MYOTONIC DYSTROPHY TYPE 1: ASSESSMENT OF EFFICIENCY, SAFETY AND THERAPEUTIC EFFECT OF CTG-REPEAT DELETION IN A MOUSE MODEL OF DISEASE 49
Absence of the GPR37/PAEL receptor impairs striatal Akt and ERK2 phosphorylation, Delta FosB expression, and conditioned place preference to amphetamine and cocaine 47
International Mouse Phenotyping Consortium IMPC. Behavior and Sensory WG 47
Time-controlled and muscle-specific CRISPR/Cas9 mediated deletion of CTG-repeat expansion in the DMPK gene 46
EUMORPHIA Final report, 2003-2005, EU FP5 contract n. QLRT-2001-00930 44
Circulating myomirs in muscle denervation: From surgical to als pathological condition 43
Ceppi mutanti modelli di resistenza alle neurotossine parkinsoniane e a psicostimolanti dopaminergici 40
Absence of the GPR37/PAEL receptor impairs striatal Akt and ERK2 phosphorylation, DeltaFosB expression, and conditioned place preference to amphetamine and cocaine 40
A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains 40
A non-invasive digital biomarker for the detection of rest disturbances in the SOD1G93A mouse model of ALS 39
Characterization of mouse mutant models of Parkinson's disease-associated receptor genes 39
How do C57 and BALB mice react to a mouse house in their home cage: encouraging results for researchers 39
Repeated administration of phencyclidine, amphetamine and MK-801 selectively impairs spatial learning in mice: a possible model of psychotomimetic drug-induced cognitive deficits 39
GPR37/PAEL-R knock-out mice show abnormalities in nigro-striatal dopaminergic function 38
WG2 Current status of Home Cage Monitoring Progress 38
Identity recognition a promising oxytocin-relevant endophenotype to stratify autism spectrum conditions 37
The Parkinson s disease associated GPR37 receptor is involved in the nigro-striatal dopaminergic signaling pathway 37
The Parkinson s disease associated Gpr37 receptor has a role during mouse testis development 37
Precocious cerebellum development and improved motor functions in mice lacking the astrocyte cilium-, patched 1-associated Gpr37l1 receptor. 37
Non-motor behavioral phenotypes depend on age and gender in mice lacking the Parkinson s disease related GPR37/Pael receptor 36
WG2 Current status of Home Cage Monitoring Update 36
Chronic sucrose intake enhances nicotine antinociception in female rats 35
Identifying genetic determinants of inflammatory pain in mice using a large-scale gene-targeted screen 35
Mice lacking the Parkinson's related GPR37/PAEL receptor show non-motor behavioral phenotypes: age and gender effect 35
Behavioural Phenotyping within the European Mouse Phenotyping Resource for Standardized Screens (EMPRESS) 35
Altered behavioral responses to psychostimulants in mice lacking the Parkinson's disease associated GRP37/Pael receptor 34
GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs 34
Involvement of the Parkinson s disease-associated GPR37 receptor in the nigro-striatal dopaminergic signaling pathway 34
MicroRNA degradation by a conserved target RNA regulates animal behavior 33
Altered dopamine signaling and MPTP resistance in mice lacking the Parkinson's disease-associated GPR37/parkin-associated endothelin-like receptor. 33
Altered dopamine receptor-mediated signalling in GR37/PAEL-R knockout mice 33
Induction of macroautophagy by overexpression of the Parkinson's disease-associated GPR37 receptor 32
A Cross-Laboratory Investigation of Timing Endophenotypes in Mouse Behavior 32
WP9&10 - Behaviour and cognition - Presentation of CNR-IBC group 31
Motor and non-motor behavioral impairments in mice lacking the Parkinson s disease associated GPR37/Pael receptor 31
Non-motor behavioral impairments depend on age and gender in mice lacking the Parkinson's disease related GPR37/Pael receptor 31
A non-invasive digital biomarker for the detection of rest disturbances in the SOD1G93A mouse model of ALS 31
Automated motor function phenotyping in mice via home cage voluntary wheel running: Cross-lab validation and comparison with rotarod 31
Altered dopamine receptor-mediated signalling in GR37/PAEL-R knockout mice 30
GPR37/PAEL receptor is a substrate of ER-induced autophagy 30
Seminario ed attività pratica per insegnanti europei della scuola media superiore 29
AUTOPHAGIC CLEARANCE OF THE PARKINSON'S DISEASE-ASSOCIATED GPR37 RECEPTOR 29
Seminario per insegnanti ed alunni scuola media superiore 29
Capitolo 18 - L'attaccamento nelle relazioni omosessuali 29
New phenotyping developments: Home cage analysis 28
European comprehensive first-line phenotyping protocol for mice: Cross-laboratory validation of a primary behavioural screen test battery 27
Altered dopamine receptor-mediated signaling in GR37/PAEL-R knockout mice 27
Altered dopaminergic function in GPR37/PAEL-R knockout mice 27
Non-motor behavioral phenotypes depend on age and gender in mice lacking the Parkinson s disease related GPR37/Pael receptor 27
A non-invasive digital biomarker for the detection of rest disturbances in the SOD1G93A mouse model of ALS 27
Macroautophagy of the GPR37 orphan receptor and Parkinson disease-associated neurodegeneration 27
WP9&10 presentation 26
Mice lacking the parkin associated receptor GPR37 show behavioral abnormalities linked to dopaminergic system alterations 26
Male olfactory cues affect mothers' behavior in mice: effects of benzodiazepines 26
Mice lacking the GPR37L1 receptor show improvements in motor learning 26
A Model of Anxiety in Lactating Female Mice: Behavioral and Pharmacological Validation 26
Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study. 26
GPR37/PAEL-R interacts with the dopamine transporter and alters dopaminergic signalling in the nigro-striatal pathway 25
MICE LACKING THE PARKINSON S DISEASE ASSOCIATED GPR37/PAEL RECEPTOR SHOW ALTERED BEHAVIORAL RESPONSES TO AMPHETAMINE AND COCAINE 25
Totale 5.058
Categoria #
all - tutte 21.025
article - articoli 7.182
book - libri 24
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 145
Totale 28.376


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202468 0 0 0 0 0 0 0 0 3 0 22 43
2024/20252.100 20 5 156 96 360 101 58 123 66 63 584 468
2025/20263.890 223 426 402 550 697 150 501 170 239 242 129 161
2026/2027131 131 0 0 0 0 0 0 0 0 0 0 0
Totale 6.189